Colorado BioScience Association Names Rick Jory Board Chair, Announces 2009 Sponsors and Appoints Seven New Board Members
Rick Jory, CEO of Sandhill Scientific, Inc., Highlands Ranch, was named chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2009 annual meeting yesterday. Jory assumes chairperson responsibilities from Jack Wheeler, MicroPhage, Inc. In other action, seven new members were named to the CBSA board of directors.
Denver, CO, April 23, 2009 --(PR.com)-- Rick Jory, CEO of Sandhill Scientific, Inc. (http://www.sandhillsci.com), Highlands Ranch, was named chairperson of the board of directors for the Colorado BioScience Association (CBSA) at its 2009 annual all-member meeting held at the Colorado National Golf Club facilities in Erie, CO, yesterday. The announcement is made by John Collar, CBSA President & CEO, who says Jory assumes chairperson responsibilities from Jack Wheeler, entrepreneur and founder of MicroPhage, Inc.
Prior to introducing Jory to the CBSA membership, Wheeler announced the following 2009 association sponsors: Platinum – Cooley Godward Kronish, Colorado State University, and the University of Colorado. Gold – Colorado Science + Technology Park at Fitzsimons, Merck & Co., Inc. and Snell & Wilmer Silver – Amgen, CaridianBCT, Denver Museum of Nature & Science, Ernst & Young, Fitzsimons Redevelopment Authority, and Pfizer. Bronze – Baxa Corporation, Dorsey & Whitney, Fairfield & Woods, Hogan & Hartson, Holland & Hart, Johnson & Johnson, OSI Pharmaceuticals, PhRMA, Poisinelli Shughart and We Work for Health.
Jory’s company, Sandhill Scientific, is a medical device manufacturer specializing in diagnostic devices primarily used by gastroenterologists and endoscopic surgeons. He holds a degree in Industrial Engineering and an MBA in Finance. Jory’s past experience includes work with both Cobe Laboratories and Valleylab. He is past Board Chair of the South Metro Denver Chamber of Commerce and former President of the Colorado Medical Device Association.
New vice chairperson of the CBSA board is Dr. Richard Duke, founding scientist of GlobeImmune and President of Apoplogic Pharmaceuticals. In other action, seven new board members were approved by the CBSA membership.
New CBSA board members include:
* Joe Bagan, CEO and President, Sharklet Technologies, www.sharklet.com
* Chris Clement, Senior Director Contracts and Business Operations, Taligen Therapeutics, www.taligentherapeutics.com
* Dick Hinson, Senior Partner, Aurora Economic Development Council, www.auroraedc.com
* Jim Kasic, Director of Clinical Research, Otologics, LLC, www.otologics.com
* Carin Kutcipal, Partner, Hogan & Hartson, www.hhlaw.com
* Mark Lupa, Partner, High Country Ventures, www.coloradofund1.com
* Frak Ronchetti, CFO, BioDesix, Inc., www.biodesix.com
Nominations for new board members were taken from the CBSA membership and acted upon by the 2009 Nominating Committee. The CBSA Board of Directors is comprised of members from the following business affiliations:
* 20% from traditional biotechnology companies
* 20% from traditional medical device companies
* 10% from research organizations
* 10% from service providers
* 10% from emerging companies
* Remainder based on need and opportunity
Reappointments of board members for approval by the membership include:
* Larry Blankenship, CEO, ValveXchange, www.valvexchange.com
* Lisa Drake, Director of Government Affairs, Monsanto, www.monsanto.com
* Jill Farnham, Executive Director, Fitzsimons Redevelopment Authority, www.colobio.com
* James Linfield, Partner, Cooley Godward Kronish, www.cooley.com
* Steve Orndorff, President and CEO, Accera, Inc., www.accerapharma.com
* Norwood Robb, Denver School of Science, www.scienceandtech.org
* William Roberts, Attorney
* Jim Skrine, Senior Director, Amgen, www.amgen.com
* Ed Wood, CEO, ArcScan, www.arcscan.com
About Colorado BioScience Association
CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com
###
Contacts:
Leah Kientz, Director of Public Policy & Programming, Colorado BioScience Association - http://www.cobioscience.com - 303-592-4088, lkientz@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations – http://www.absolutelypr.com – 303-984-9801, maggie@absolutelypr.com
Prior to introducing Jory to the CBSA membership, Wheeler announced the following 2009 association sponsors: Platinum – Cooley Godward Kronish, Colorado State University, and the University of Colorado. Gold – Colorado Science + Technology Park at Fitzsimons, Merck & Co., Inc. and Snell & Wilmer Silver – Amgen, CaridianBCT, Denver Museum of Nature & Science, Ernst & Young, Fitzsimons Redevelopment Authority, and Pfizer. Bronze – Baxa Corporation, Dorsey & Whitney, Fairfield & Woods, Hogan & Hartson, Holland & Hart, Johnson & Johnson, OSI Pharmaceuticals, PhRMA, Poisinelli Shughart and We Work for Health.
Jory’s company, Sandhill Scientific, is a medical device manufacturer specializing in diagnostic devices primarily used by gastroenterologists and endoscopic surgeons. He holds a degree in Industrial Engineering and an MBA in Finance. Jory’s past experience includes work with both Cobe Laboratories and Valleylab. He is past Board Chair of the South Metro Denver Chamber of Commerce and former President of the Colorado Medical Device Association.
New vice chairperson of the CBSA board is Dr. Richard Duke, founding scientist of GlobeImmune and President of Apoplogic Pharmaceuticals. In other action, seven new board members were approved by the CBSA membership.
New CBSA board members include:
* Joe Bagan, CEO and President, Sharklet Technologies, www.sharklet.com
* Chris Clement, Senior Director Contracts and Business Operations, Taligen Therapeutics, www.taligentherapeutics.com
* Dick Hinson, Senior Partner, Aurora Economic Development Council, www.auroraedc.com
* Jim Kasic, Director of Clinical Research, Otologics, LLC, www.otologics.com
* Carin Kutcipal, Partner, Hogan & Hartson, www.hhlaw.com
* Mark Lupa, Partner, High Country Ventures, www.coloradofund1.com
* Frak Ronchetti, CFO, BioDesix, Inc., www.biodesix.com
Nominations for new board members were taken from the CBSA membership and acted upon by the 2009 Nominating Committee. The CBSA Board of Directors is comprised of members from the following business affiliations:
* 20% from traditional biotechnology companies
* 20% from traditional medical device companies
* 10% from research organizations
* 10% from service providers
* 10% from emerging companies
* Remainder based on need and opportunity
Reappointments of board members for approval by the membership include:
* Larry Blankenship, CEO, ValveXchange, www.valvexchange.com
* Lisa Drake, Director of Government Affairs, Monsanto, www.monsanto.com
* Jill Farnham, Executive Director, Fitzsimons Redevelopment Authority, www.colobio.com
* James Linfield, Partner, Cooley Godward Kronish, www.cooley.com
* Steve Orndorff, President and CEO, Accera, Inc., www.accerapharma.com
* Norwood Robb, Denver School of Science, www.scienceandtech.org
* William Roberts, Attorney
* Jim Skrine, Senior Director, Amgen, www.amgen.com
* Ed Wood, CEO, ArcScan, www.arcscan.com
About Colorado BioScience Association
CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. For more information, visit http://www.cobioscience.com
###
Contacts:
Leah Kientz, Director of Public Policy & Programming, Colorado BioScience Association - http://www.cobioscience.com - 303-592-4088, lkientz@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations – http://www.absolutelypr.com – 303-984-9801, maggie@absolutelypr.com
Contact
Colorado BioScience Association
Maggie Holben
303-984-9801
http://www.cobioscience.com
Maggie Holben
303-984-9801
http://www.cobioscience.com
Contact
Categories